Entactogen: Difference between revisions
>Oskykins |
>Oskykins |
||
Line 46: | Line 46: | ||
*[[Stimulants]] | *[[Stimulants]] | ||
*[[Psychedelics]] | *[[Psychedelics]] | ||
*[[MDAI]] | |||
*[[MDMA]] | |||
*[[Empathy, love, and sociability enhancement]] | |||
==References== | ==References== | ||
* Nichols, D.E., Hoffman, A.J., Oberlender, R.A., Jacob P 3rd & [[Alexander Shulgin|Shulgin A.T.]] ''Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class'' 1986 J Med Chem 29 2009-15 | * Nichols, D.E., Hoffman, A.J., Oberlender, R.A., Jacob P 3rd & [[Alexander Shulgin|Shulgin A.T.]] ''Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class'' 1986 J Med Chem 29 2009-15 | ||
* Nichols, D.E. ''Differences between the mechanism of action of MDMA, MBDB, and the classic [[Psychedelics, Dissociatives and Deliriants|hallucinogen]]s. Identification of a new therapeutic class: entactogens'' 1986 J Psychoactive Drugs 18 305-13 | * Nichols, D.E. ''Differences between the mechanism of action of MDMA, MBDB, and the classic [[Psychedelics, Dissociatives and Deliriants|hallucinogen]]s. Identification of a new therapeutic class: entactogens'' 1986 J Psychoactive Drugs 18 305-13 |